FDA Researchers Contribute Insights Into Avian Flu Virus (Medical News Today) An in-depth analysis of blood from patients recovering from the H5N1 avian influenza virus has provided important insights into how to combat the potentially lethal virus. The findings by U.S. Food and Drug Administration scientists and collaborators better explain what part of the "bird flu" virus is seen by the immune system once a person becomes infected.
FDA Fails To Consider Risks Of Over The Counter Plan B (Medical News Today) Moira Gaul, Family Research Council's Director of Women's and Reproductive Health, released the following statement regarding the Obama Administration's decision to sell the morning-after-pill to 17-year-olds without a prescription. "The Obama Administration is permitting a judge to make a scientific decision as to the safety of the over-the-counter sale of Plan B.
FDA Gives Clinical Trial Green Light On Drug To Treat Alzheimer's Disease (Medical News Today) The Food and Drug Administration (FDA) has given the Blanchette Rockefeller Neurosciences Institute (BRNI) the go-ahead to conduct Phase II clinical trials of Bryostatin for the treatment of Alzheimer's disease patients. The drug showed pre-clinical efficacy to not only treat Alzheimer's disease symptoms, but also its underlying causes.